4//SEC Filing
Lingamneni Anila 4
Accession 0001127602-24-016171
CIK 0000313143other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:55 PM ET
Size
8.9 KB
Accession
0001127602-24-016171
Insider Transaction Report
Form 4
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
- Tax Payment
Common Stock
2024-05-17$95.73/sh−349$33,410→ 11,291 total - Award
Non-qualified Stock Option (Right to Buy)
2024-05-17+7,461→ 7,461 totalExercise: $95.73Exp: 2031-05-17→ Common Stock (7,461 underlying) - Award
Common Stock
2024-05-17+3,394→ 14,685 total
Footnotes (5)
- [F1]Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
- [F2]This number includes unvested RSUs previously reported.
- [F3]The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F4]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F5]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001808414
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:55 PM ET
- Size
- 8.9 KB